Results 131 to 140 of about 15,127 (297)

SPLENIC HOMOTRANSPLANTATION. [PDF]

, 1964
During the past 12 months, five clinical whole-organ splenic homotransplantations have been carried out with the objective of providing active immunologic tissue for the recipient patients.
FUDENBERG, H, MARCHIORO, TL, RIFKIND, D, ROWLANDS, DT, STARZL, TE, WADDELL, WR   +5 more
core  

Bone marrow cells in X-linked agammaglobulinemia express pre-B-specific genes (lambda-like and V pre-B) and present immunoglobulin V-D-J gene usage strongly biased to a fetal-like repertoire. [PDF]

, 1993
Michèle Milili, Françoise Le Deist, Geneviève de Saint Basile, Alain Fischer, M. Fougereau, Claudine Schiff   +5 more
openalex   +1 more source

Characterization of a CD38-like 78-kilodalton soluble protein released from B cell lines derived from patients with X-linked agammaglobulinemia. [PDF]

, 1998
Roberto Mallone, S Ferrua, M. Morra, Elena Zocchi, Kapil Mehta, L. D. Notarangelo, Fabio Malavasi   +6 more
openalex   +1 more source

Mutations in the Human λ5/14.1 Gene Result in B Cell Deficiency and Agammaglobulinemia [PDF]

, 1998
Yoshiyuki Minegishi, Elaine Coustan‐Smith, Yui‐Hsi Wang, Max D. Cooper, Dario Campana, Mary Ellen Conley   +5 more
openalex   +1 more source

BTKbase, mutation database for X-linked agammaglobulinemia (XLA) [PDF]

, 1997
Mauno Vihinen, B. H. Belohradsky, Robert N. Haire, Elke Holinski‐Feder, Sau‐Ping Kwan, Ilkka Lappalainen, Heikki Lehväslaiho, Tracy Lester, A Meindl, HD Ochs, Jimmy Ollila, Igor Vořechovský, Michael Weiss, Smith Rjh   +13 more
openalex   +1 more source

New insights in the use of immunoglobulins for the management of immune deficiency (PID) patients [PDF]

, 2017
Immunoglobulin replacement therapy (IRT) is standard treatment for patients with primary immunodeficiency (PID). Because most of the patients with PID will require long life-time immunoglobulin replacement therapy, the quality of the prescribed ...
Alfa Cissé, Ousmane, Bernatowska, Ewa, Jolles, Stephen, Krivan, Gergely, Lopes Granados, Eduardo, Ouaja, Rabye, Paolantonacci, Phillipe   +6 more
core  

GRANULOPOIESIS IN X-LINKED AGAMMAGLOBULINEMIA PATIENTS: THE EFFECTS OF IN VITRO AND IN VIVO IMMUNOGLOBULINES 60 [PDF]

, 1997
Serge Gradstein, Talia Hahn, D Shtoger, Yoram Barak   +3 more
openalex   +1 more source

Mutations in topoisomerase IIβ result in a B cell immunodeficiency. [PDF]

, 2019
B cell development is a highly regulated process involving multiple differentiation steps, yet many details regarding this pathway remain unknown. Sequencing of patients with B cell-restricted immunodeficiency reveals autosomal dominant mutations in ...
Austin, Caroline A, Booshehri, Laela M, Broderick, Lori, Brydges, Susannah D, Cowell, Ian G, Croker, Ben A, Frazer, Kelly A, Gebauer, Corinna, Guaderrama, Marisela, Hakonarson, Hakon, Harr, Margaret, Hoffman, Hal M, Hügle, Boris, Kucharova, Karolina, Li, Dong, McGeough, Matthew D, Patel, Niraj C, Putnam, Christopher D, Wang, Jian, Xu, Xun, Yost, Shawn, Zackai, Elaine, Zhang, Jianguo   +22 more
core  

Stability and peptide binding specificity of Btk SH2 domain: Molecular basis for X‐linked agammaglobulinemia [PDF]

, 2000
Shiou‐Ru Tzeng, Ming‐Tao Pai, Chih‐Wei Wu, Jya‐Wei Cheng, Feng‐Di T. Lung, Peter P. Roller, Benfang Lei, Chih‐Jen Wei, Shiao‐Chun Tu, Shi‐Han Chen, Wen‐Jue Soong   +10 more
openalex   +1 more source

Involvement of Bruton's tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production. [PDF]

, 1998
We investigated the role of Bruton's tyrosine kinase (Btk) in FcepsilonRI-dependent activation of mouse mast cells, using xid and btk null mutant mice.
Alt, FW, Galli, SJ, Goldfeld, AE, Han, W, Hartman, SE, Hata, D, Inagaki, N, Kawakami, T, Kawakami, Y, Khan, WN, Kitamura, T, Lantz, CS, Maeda-Yamamoto, M, Miura, T, Nagai, H, Witte, ON, Yao, L   +16 more
core